Guardion Health Sciences, Inc. (GHSI) |
| 3.25 0.03 (0.93%) 03-09 16:00 |
| Open: | 3.25 |
| High: | 3.25 |
| Low: | 3.25 |
| Volume: | 664 |
| Market Cap: | 4(M) |
| PE Ratio: | -0.79 |
| Exchange: | Other OTC |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.09 |
| Resistance 1: | 6.07 |
| Pivot price: | 5.28 |
| Support 1: | 5.32 |
| Support 2: | 4.86 |
| 52w High: | 18 |
| 52w Low: | 3.04 |
Guardion Health Sciences, Inc. (GHSI), along with its various affiliates, functions as a specialized healthcare enterprise operating within the United States. The company's operations are divided into two primary segments: Medical Foods and Nutraceuticals, and Medical Devices. Under its Medical Foods division, Guardion Health Sciences offers Lumega-Z, a therapeutic food designed to replenish and restore the eye's macular protective pigment. It also provides GlaucoCetin, a specialized medical food formulated to support and safeguard the mitochondrial function of optic nerve cells, and to improve ophthalmic artery blood flow in patients afflicted with glaucoma. In the Medical Devices sector, the company supplies MapcatSF, a device used to precisely measure macular pigment optical density. It also markets the CSV-1000, which conducts self-calibrated tests to ensure accurate luminance and contrast levels, and the CSV-2000, a digital system for standardized contrast sensitivity testing. Moreover, Guardion Health Sciences develops, manufactures, and distributes equipment and accessories for standardized vision screening under the VectorVision name, utilized by vision care professionals in clinical research, real-world diagnostic evaluations, and occupational vision assessments. Furthermore, the company is actively developing ImmuneSF, a new nutraceutical blend, and manages a comprehensive collection of nutritional supplement products marketed under its NutriGuard brand. Its medical food items are distributed directly to consumers via its online store, guardionhealth.com. Guardion Health Sciences, Inc. was established in 2009 and is headquartered in San Diego, California.
| EPS | -0.580 |
| Book Value | 11.300 |
| PEG Ratio | 1.04 |
| Gross Profit | 1.021 |
| Profit Margin (%) | -35.49 |
| Operating Margin (%) | 23.10 |
| Return on Assets (ttm) | -0.6 |
| Return on Equity (ttm) | -2.3 |
Thu, 24 Apr 2025
Guardion Health Sciences (GHSI) Stock Price, News & Analysis - Stock Titan
Fri, 04 Oct 2024
Guardion Health Sciences Announces Delisting and New Interim CEO - Yahoo Finance
Thu, 03 Oct 2024
Houston-based health supplements co. to delist from Nasdaq, dissolve - The Business Journals
Fri, 23 Aug 2024
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.14% - Investing.com
Tue, 13 Aug 2024
Alantra advises Guardion Health on strategic sale of Viactiv to KingdomWay Group - Alantra
Fri, 31 May 2024
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |